Clinical Trials on Tyrosinemia Type 3 in Poland

Total 4223 results

Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment (NIVONASO-21)

Nasopharyngeal Cancer

Poland
Oregon Health and Science University
The Leona M. and Harry B. Helmsley Charitable Trust

Completed

The Multi-Sensor Distance Accuracy Study

Type 1 Diabetes Mellitus

United States
Oregon Health and Science University

Recruiting

DailyDose Smart Snack Study for T1D on MDI

Type 1 Diabetes Mellitus With Hypoglycemia

United States
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (SERENADE)

Type 2 Diabetes Mellitus

United States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
Oregon Health and Science University

Completed

Exercise Physiology Study

Hypoglycemia | Type 1 Diabetes Mellitus

United States
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Leukemia

United States, Poland
Medical University of Warsaw

Recruiting

Possible Differences in HCC Course Depending on DAA Treatment

Liver Cirrhosis | Carcinoma, Hepatocellular | Hepatitis C, Chronic | Drug Effect | Hepatitis C Virus Infection, Response to Therapy of | Drug Side Effect

Poland
Oregon Health and Science University
DexCom, Inc.

Completed

Evaluation of Physician-based Decision Support

Exercise | Type 1 Diabetes Mellitus | CGM | MDI

United States
Legacy Health System
Juvenile Diabetes Research Foundation; Oregon Health and Science University

Completed

Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver

Type 1 Diabetes Mellitus

United States
Isofol Medical AB

Completed

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Osteosarcoma

Poland, Czechia, Hungary, Sweden
Polish Myeloma Consortium
Janssen-Cilag Ltd.; Bioscience, S.A.

Recruiting

Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma (PREDATOR)

Multiple Myeloma

Poland
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Real-time Adaptation to Changes in Insulin Sensitivity

Type 1 Diabetes Mellitus

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma

United States
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NHL)

Leukemia | Non-Hodgkin's Lymphoma | NHL

United States, Poland
Isofol Medical AB

Completed

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX (FORTO)

Osteosarcoma

Norway, Sweden, Hungary, Poland
Ipsen

Withdrawn

Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice (NETways)

Neuroendocrine Tumors

Poland
Helios Albert-Schweitzer-Klinik Northeim

Completed

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy (EC-Cap-SC)

Colorectal Polyps | Colorectal Adenomas

Germany, Poland
Pfizer

Terminated

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Type 2 Diabetes Mellitus

United States
MedImmune LLC

Terminated

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States, Poland
Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

Georgia, Bulgaria, Poland
Erasme University Hospital

Unknown

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Belgium, Poland
Radboud University Medical Center

Active, not recruiting

Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D (Honeymoon)

Type 1 Diabetes Mellitus

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Brain Clock and Insulin Resistance

Insulin Resistance | Type 2 Diabetes

Netherlands
Hoffmann-La Roche

Completed

A Study of Mircera in Anemic Patients With Multiple Myeloma

Anemia

Poland, Czechia
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

United States
Maria Sklodowska-Curie National Research Institute...

Unknown

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (UN-RESARC)

Sarcoma | Leiomyosarcoma | Fibrosarcoma | Liposarcoma | Myxoid Liposarcoma | Myosarcoma | Histiocytic Sarcoma | Pleomorphic Liposarcoma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Myxofibrosarcoma | Dedifferentiated Liposarcoma | Malignant Peripheral Nerve Sheath Tumors | Malignant Triton Tumor | Pleomorphic... and other conditions

Poland
Abbott Products
Quintiles, Inc.

Completed

A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes

Type 2 Diabetes

Bulgaria, Poland, South Africa
Janssen Research & Development, LLC

Withdrawn

A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma (MonumenTAL-5)

Relapsed/ Refractory Multiple Myeloma

United States, Poland
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Type I Hypersensitivity

United States
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Type 1 Diabetes

United States
Maria Sklodowska-Curie National Research Institute...

Unknown

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas (SINDIR)

Sarcoma | Leiomyosarcoma | Fibrosarcoma | Myxoid Liposarcoma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Alveolar Soft Part Sarcoma | Liposarcoma, Dedifferentiated | Clear Cell Sarcoma | Malignant Peripheral Nerve Sheath Tumors | Pleomorphic Rhabdomyosarcoma

Poland
Legacy Health System
DexCom, Inc.

Suspended

Effects of HBO on Glucose in Patients With DM

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Amsterdam UMC, location VUmc
AstraZeneca

Completed

DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2 (DECREASE)

Obesity | Type 2 Diabetes Mellitus

Netherlands
Legacy Health System
Juvenile Diabetes Research Foundation; Oregon Health and Science University

Completed

Physiologic Response to Glucagon at Varying Insulin Levels

Type 1 Diabetes Mellitus

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Heart Foundation

Recruiting

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes (DOTAFLAME)

Type 2 Diabetes

Netherlands
Oregon Health and Science University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Context Aware Data Gathering Study

Type 1 Diabetes

United States
Oregon Health and Science University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Two Way Crossover Closed Loop Study R-AP vs MPC

Type 1 Diabetes

United States
Oregon Health and Science University
Juvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable...

Completed

Two Way Crossover Closed Loop Study MPC vs FMPD

Type 1 Diabetes

United States
Oregon Health and Science University

Completed

Four Way Crossover Closed Loop With Exercise Detection

Type 1 Diabetes

United States
Oregon Health and Science University

Completed

Exercise Detection Study

Type 1 Diabetes

United States
Legacy Health System
Juvenile Diabetes Research Foundation; Oregon Health and Science University

Completed

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

Type 1 Diabetes

United States
Dr. Reddy's Laboratories Limited
PharmaNet

Completed

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Type II Hyperlipidemia

Ukraine, Poland, Italy
Diabeter Nederland BV

Recruiting

Evaluation of CloudCare in the Treatment of Type 1 Diabetes

Type 1 Diabetes

Netherlands
Oregon Health and Science University

Completed

INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes

Primary Health Care | Type II Diabetes | Behavioral Health

United States
Oregon Health and Science University

Completed

Assessment of a Decision Support Tool in Participants With Type 1 Diabetes

Type 1 Diabetes

United States
Biodel

Completed

To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy

Type 1 Diabetes Mellitus

United States
University of Chicago

Active, not recruiting

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

Multiple Myeloma

United States, Poland
Oregon Health and Science University
Xeris Pharmaceuticals

Completed

Three Way Crossover Closed Loop Study With Xeris Glucagon

Type1diabetes

United States
Oregon Health and Science University

Suspended

Effects of DPP-4 Inhibition on Triglycerides

Type 2 Diabetes | Hypertriglyceridemia

United States

Clinical Trials on Tyrosinemia Type 3 in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations